Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Accure Therapeutics logo — R&D pharma dedicated to developing innovative medicines to t...

Accure Therapeutics

R&D pharma dedicated to developing innovative medicines to treat patients suffering from Central nervous system diseases

Founded 2020 Spain Spain 12 employees Grant Total: $9.20M Biotechnology, Health Care +1

General Information

Company Name Accure Therapeutics
Founded Year 2020
Location Spain Spain
Founders / Decision Makers
Team member
Employees 12
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Accure Therapeutics. To contact Accure Therapeutics, visit accure.health.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Accure Therapeutics compare?

A PDF of Accure Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Accure Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Accure Therapeutics

Accure Therapeutics is a R&D pharma company with a focus on developing innovative medicines for patients suffering from severe central nervous system diseases. The company's mission is to impede the degeneration and death of dysfunctional neurons and their glial support system. By developing Disease Modifying Therapies, Accure Therapeutics aims to correct pathological changes responsible for diseases such as Optic Neuritis, Multiple Sclerosis, Parkinson’s Disease, and Epilepsy. Since its founding in 2020 in Spain, the company has attracted $1.60M in its latest investment round, led by the Michael J. Fox Foundation and the Luxembourg National Research Fund. With a strong industry presence in Biotechnology, Health Care, and Health and Wellness, Accure Therapeutics is positioned to make significant contributions in treating central nervous system diseases.

Business keywords: neuroprotection, multiple sclerosis, optic neuritis, Parkinson's disease, epilepsy, CNS diseases, pharmaceutical industry, remyelination, rare diseases, neuromyelitis optica, drug development, clinical research, neurobiology, innovative medicine, central nervous system

Services & Products

Research and development of innovative medicines for CNS diseases

Target Customers

Patients suffering from Central Nervous System (CNS) diseases

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Select $1.60M 2
Michael J. Fox Foundation, Luxembourg National Research Fund
07 Apr 2025
Series A €7.60M 3
Alta Life Sciences Kinled Holding Ltd
Alta Life Sciences, Kinled Holding Ltd +1
26 May 2020

Latest News

View All
Europe’s biggest seed rounds of Q1 2025, Enpal bags €110M boost, and Scania acquires bankrupt Northv... — Tech
Europe’s biggest seed rounds of Q1 2025, Enpal bags €110M boost, and Scania acquires bankrupt Northvolt Systems' Industrial Division
Tech Apr 11, 2025
Accure Therapeutics secures $1.6M from Michael J. Fox Foundation and Luxembourg national research Fu... — Tech
Accure Therapeutics secures $1.6M from Michael J. Fox Foundation and Luxembourg national research Fund
Tech Apr 07, 2025

Accure Therapeutics Alternatives & Competitors

View All Alternatives
Accure Therapeutics vs
Bionure
Bionure Spain

Clinical stage biotech developing new drugs for CNS diseases.

Series A
8 employees
Biotechnology, Health Care
Accure Therapeutics vs
Neuralstem, Inc.
Neuralstem, Inc.

Advancing stem cell technology to treat central nervous system diseases and deliver hope for incurab...

Post-IPO Equity
3 employees
Biotechnology, Health Care
Accure Therapeutics vs
UCB
UCB Belgium

We’re #TeamUCB, a global biopharmaceutical company. 💙 Inspired by patients 🔬 Driven by science

IPO
15278 employees
Biotechnology, Health Care
View all alternatives

FAQ About Accure Therapeutics

R&D pharma dedicated to developing innovative medicines to treat patients suffering from Central nervous system diseases
Accure Therapeutics was founded in 2020.
Accure Therapeutics is headquartered in Spain.
Accure Therapeutics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on neuroprotection, multiple sclerosis, optic neuritis and Parkinson's disease. Its customers include Patients suffering from Central Nervous System (CNS) diseases.
Accure Therapeutics has approximately 12 employees.
Accure Therapeutics has completed 2 funding rounds, raising a total of $9.20M. The latest funding stage is Grant.
Accure Therapeutics offers: Research and development of innovative medicines for CNS diseases.
Top alternatives and competitors to Accure Therapeutics include Bionure, Neuralstem, Inc., UCB, Disarm Therapeutics, Novoron Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Accure Therapeutics and Bionure are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Accure Therapeutics, https://bouncewatch.com/company/accure-therapeutics, updated 13 April 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout